Categories: AppCareDrugOptimizePersonalPlatformTechnologyTimeUniversity
Axithra is a spin-off from Ghent University and imec, developing a platform to quickly and accurately measure and monitor drug concentrations in blood, paving the way for treatments tailored to the specific needs of each individual, at any given time.
The first application is focusing on personalizing beta-lactam antibiotics treatments in the intensive care unit. The company’s platform is based on proprietary optical and photonics technology and will allow physicians to optimize patient care by enabling personalized treatments.
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.09.2023 | Seed | $10.7M | - |
Mentions in press and media 1
Reviews 0
